ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,965
0,51%
Bitcoin
57 450,85
-1,35%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cogent Biosciences Inc (COGT)

  7. Cogent Biosciences Inc (COGT) Actualités

COGT Cogent Biosciences Inc

6,60
0,10 (1,54%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cogent Biosciences Inc COGT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,10 1,54% 6,60 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,50 6,46 7,257 6,93 6,50
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/4/202415:00GLOBECogent Biosciences Presents Data Highlighting Potential..
26/2/202422:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202415:13EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202414:30EDGAR2Form 8-K - Current report
26/2/202414:00GLOBECogent Biosciences Reports Recent Business Highlights and..
22/2/202420:30GLOBECogent Biosciences Announces Positive Part 1b Data from..
17/2/202400:55EDGAR2Form SC 13D/A - General statement of acquisition of..
17/2/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202418:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:35EDGAR2Form 8-K - Current report
14/2/202413:00GLOBECogent Biosciences Announces Oversubscribed $225 Million..
09/2/202422:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202415:00GLOBECogent Biosciences to Present SUMMIT Part 1b Data with..
25/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202414:00GLOBECogent Biosciences Announces Planned 2024 Milestones for..
04/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:00GLOBECogent Biosciences Announces Presentation at the 42nd Annual..
11/12/202314:04EDGAR2Form 8-K - Current report
11/12/202313:55GLOBECogent Biosciences Announces Positive Data from Ongoing..
09/12/202319:30GLOBECogent Biosciences Announces Positive Initial Data from..
07/12/202315:00GLOBECogent Biosciences Presents New Preclinical Data..
04/12/202314:00GLOBECogent Biosciences to Host Investor Webcast on December 11,..
29/11/202314:00GLOBECogent Biosciences Announces Poster Presentations at..
07/11/202313:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202314:18EDGAR2Form 8-K - Current report
02/11/202314:00GLOBECogent Biosciences Reports Recent Business Highlights and..
14/10/202318:30GLOBECogent Biosciences Presents Preclinical Data Highlighting..
03/10/202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202314:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202314:14EDGAR2Form 8-K - Current report
08/8/202314:00GLOBECogent Biosciences Reports Recent Business Highlights and..
05/7/202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/6/202322:01GLOBECogent Biosciences Announces Closing of Upsized Public..
07/6/202315:00GLOBECogent Biosciences Announces Participation in the Jefferies..
07/6/202302:25GLOBECogent Biosciences Announces Pricing of Upsized Public..
06/6/202322:05GLOBECogent Biosciences Announces Proposed Public Offering of..
03/6/202320:15GLOBECogent Biosciences Announces Positive Lead-In Data from..
23/5/202314:00GLOBECogent Biosciences to Host Investor Webcast to Discuss..
09/5/202314:00GLOBECogent Biosciences Reports Recent Business Highlights and..

Dernières Valeurs Consultées

NASDAQ
COGT
Cogent Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés